Binding of U2 small nuclear ribonucleoprotein (snRNP) to the pre-mRNA is an early and important step in spliceosome assembly. We searched for evidence of cooperative function between yeast U2 small nuclear RNA (snRNA) and several genetically identified splicing (Prp) proteins required for the first chemical step of splicing, using the phenotype of synthetic lethality. We constructed yeast strains with pairwise combinations of 28 different U2 alleles with 10prp mutations and found lethal double-mutant combinations withprpS, -9, -11, and -21 but not with prp3, 4, -8, or -19. Many U2 mutations in highly conserved or invariant RNA structures show no phenotype in a wild-type PRP background but render mutant prp strains inviable, suggesting that the conserved but dispensable U2 elements are essential for efficient cooperative function with specific Prp proteins. Mutant U2 snRNA fails to accumulate in synthetic lethal strains, demonstrating that interaction between U2 RNA and these four Prp proteins contributes to U2 snRNP assembly or stability. Three of the proteins (Prp9p, Prpllp, and Prp2lp) are associated with each other and pre-mRNA in U2-dependent splicing complexes in vitro and bind specifically to synthetic U2 snRNA added to crude splicing extracts depleted of endogenous U2 snRNPs. Taken together, the results suggest that Prp9p, -llp, and -21p are U2 snRNP proteins that interact with a structured region including U2 stem loop Ila and mediate the association of the U2 snRNP with pre-mRNA.
Splicing of nuclear pre-mRNA requires a sophisticated ribonucleoprotein (RNP) complex called the spliceosome. The spliceosome is built on an intron-containing transcript by the sequential binding of small nuclear RNPs (snRNPs) to each other and to specific sites on the transcript, so that the pre-mRNA is properly arranged for splicing (20, 21) . Before, during, and after the cleavage-ligation steps of splicing take place, the spliceosome is acted upon by a series of extrinsic factors, some of which bind transiently and trip a limited set of steps in the sequence (15, 29, 48) . The events that define the transition from one state to the next during spliceosome assembly and function are both compositional and conformational: snRNPs and extrinsic factors are added and removed, and RNA-RNA interactions between the small nuclear RNAs (snRNAs) or between the snRNAs and the pre-mRNA within the spliceosome may be established and dissolved (42) . Splicing factors include a family of proteins with ATP binding domains suggesting a means for driving the process forward and ensuring the accuracy of events (20, 21) .
The expectation that alternative splicing is achieved by regulated spliceosome assembly has placed the early steps of splicing complex formation under close scrutiny. Using substrate commitment experiments, several investigations have led to a similar set of conclusions for both systems (27, 32, 38, 49, 50) . Substrate (also referred to as template) commitment is defined as an event that leads to the inclusion of highly labeled pre-mRNA substrate molecules in later complexes despite the subsequent addition of a large excess of unlabeled substrate. By this definition, Ul snRNPs stably bind pre-mRNA in a fashion dependent on correct 5' splice site and either branchpoint (yeast) or polypyrimidine 3' splice site (mammalian) sequences to form a commitment complex in a reaction requiring neither ATP nor the U2 snRNP (for a review, see reference 42) . Following assembly of the commitment complex, U2 snRNP binds near the branchpoint and its association is stabilized in an ATP-dependent step to form the prespliceosome (complex III or B in yeast extracts, A complex in mammalian cells). Spliceosomes are formed when the U4/6.5 multi-snRNP complex binds to the prespliceosome (42) . Some complexes observed in vitro are clearly related to splicing, requiring correct signals in pre-mRNA and snRNPs for their formation, but are refractory to the chase (for example, the mammalian -ATP complex [28] ) or occur in defiance of an apparent ATP requirement (for example, the U1-4U complex [33] ). Whether the commitment phenomena observed in vitro represent commitment during regulation of splicing in vivo is an open question.
In the yeast system, the biochemical approaches to the question of spliceosome assembly have been complemented by the isolation and characterization of temperature-sensitive mutations defective in splicing (the prp mutants [21, 45] ).
Among the elements required for steps leading to the formation of the prespliceosome in yeast extracts are the PRP5 (46) , PRP9 (1, 31, 46) , PRPJJ (10, 46) , and PRP21/SPP91 (2, 11) gene products, as well as parts of Ul snRNA (33) and U2 snRNA (56) . The relationship of the functions of these components to each other in the pathway has not been determined. In some cases, the protein sequence provides clues; for example, the Prp5 protein contains an ATP binding domain, suggesting a role in an ATP-dependent step (16) . In other cases, protein-protein interactions have been detected. Genetic suppression data (11) and results using the yeast two-hybrid system for detecting protein-protein interactions (14, 18) show that PRP21 interacts with PRP9 (30, 31) . Similarly PRPII interacts with PRP21 and possibly indirectly with PRP9 through its interaction with PRP21 (30) . Genetic interactions between pairwise combinations of the proteins also suggest functional interactions (46) . How these protein-protein interactions contribute to the process of U2 snRNP addition to the assembling spliceosome remains to be determined.
Relationships between the yeast Prp proteins and mammalian splicing factors, snRNP proteins, and proteins associated with purified presplicing complexes have been detected (7, 8, 19) . Two mammalian proteins with structural similarity to yeast Prp9p and Prpllp are found associated with a 17S form of the U2 snRNP and are components of the biochemically defined splicing factor SF3a (5, 8, 9) . SF3a cannot bind to U2 snRNP in the absence of another biochemically defined splicing factor, SF3b (8) . The mammalian homologs to Prp9p and Prpllp are also found associated with purified prespliceosomes (7). Oligonucleotide-directed RNase H degradation of U2 snRNA in extracts shows that binding of these proteins to form the 17S U2 snRNP requires the highly conserved 5' half of U2 (6) .
Genetic studies of yeast U2 have identified RNA elements required for U2 function during splicing, including a site of interaction with the intron branchpoint (44), a conserved internal U2 stem loop Ila (4) , and a region required for the second step of splicing (36) that interacts with U6 snRNA (35) . Mutations in stem Ila that cause cold-sensitive growth also cause cold-sensitive prespliceosome formation (56) , indicating a role for this structure in spliceosome assembly. We have been interested in how the U2 snRNP is incorporated into the spliceosome and are using the genetic system of the yeast Saccharomyces cerevisiae to identify proteins or RNAs that influence the function of U2 snRNA. In this report we describe synthetic lethal interactions (20a, 23) between a panel of U2 snRNA mutations and mutations in the yeast PRPS, -9, -11, and -21 genes. Some of the U2 mutations are in highly conserved residues and have no detectable phenotype in a wild-type background (3) yet are lethal if the strain carries a temperature-sensitive pip mutation. Using a glucose-repressible wild-type U2 gene (40, 49) , we show that interactions between U2 and Prp5p, -9p, -llp, and -21p are important for U2 snRNP stability in vivo. We also provide biochemical evidence that three of the proteins are associated with premRNA in a complex that requires U2 snRNP for its formation. The same three proteins bind synthetic U2 RNA added to crude splicing extracts depleted of endogenous U2, suggesting they are part of the U2 snRNP.
MATERIALS AND METHODS
Yeast strains. Yeast strains were grown according to standard procedures (51) . Strains carrying the prp mutations are listed below. These strains were provided by S. Ruby, and their construction has been described elsewhere (46) . The strains used have the following genotypes: SRYWTa, AL4Ta PRP+ ade-his3-A200 his4 leu2 trpl-ura3-52; SRY3-lb, AL4Tot prp3-1 ade-his3 leu2 tyrl ura-; SRY4-lb, MAToc prp4-1 adeleu2-3,112 lys2 ura3-52; SRY5-lb, AL4Tot prpS-l ade-his3-A200 leu2 tyrl ura3-52; SRY5-3b, ALTot prp5-3 ade-his3A leu2-3,112 tyrl ura3-52; SRY8-lb, AL4To: prp8-1 ade-his3-A200 leu2 trp-tyrl ura3-52; SRY9-ld, AVTot prp9-1 adehis3-A200 leu2 tyrl ura3-52; SRY9-2f, ALTt prp9-2 adehis3-A200 leu2 trp-tyrl ura3-52; SRY11-ld, MA4To prpll-l ade-his-his4 leu2 tyrl ura3-52; SRY19-lb, MATot prpl9-1 ade-his-leu2 trp] tyrl ura3-52; and SRY21-lb, MAITot prp21-1 ade-his-leu2 tyrl ura3-52.
Each of these strains was transformed with a Hindlll fragment carrying sequences in the order U2 promoter distal-URA3-GAL-U2 promoter proximal such that the fragment is targeted to the U2 locus and replaces the wild-type U2 promoter with a GAL-regulated U2 promoter (24, 40) . Transformants were selected on synthetic complete medium with galactose as a carbon source lacking uracil (SCGal-Ura) and screened for galactose dependence by testing for failure to grow on synthetic complete with glucose lacking uracil (SCDUra), and the integration event was confirmed by Southern blotting. These strains were transformed with a LEU2, centromere plasmid carrying the U2 allele to be tested (YCpU2 [25] ), selected on SCGal-Ura,-Leu, and assayed for growth on media containing glucose (SCD-Ura or YPD) or galactose (SCGalUra or YPGal) at 26°C.
RNA isolation and analysis. Stationary cultures in SCGalUra were used to inoculate starter cultures in YPGal medium. Cells were grown in liquid YPGal at 25°C to an optical density at 600 nm (OD600) of 1 to 2 and diluted into liquid YPD to an OD600 of 0.1 to 0.3 to repress U2 synthesis. Cells were grown at 25°C for 16 to 20 h to allow loss of the wild-type U2. As wild-type U2 is depleted, growth is arrested in synthetic lethal strains at an OD of about 1 to 2. Variations in the rate of cell growth between different strains during this period correlated with strain background rather than U2 allele. Total RNA was isolated from 50-ml aliquots of culture at an OD of 0.5 to 3.0 essentially as described previously (4) . Cell pellets were resuspended in 0.4 ml of AK buffer (AK buffer is 1 g of triisopropylnaphthalene sulfonic acid, 6 g of sodium p-aminosalicylate, 1.17 g of sodium chloride, 6 ml of phenol, and double-distilled H20 to 100 ml). The mixture was transferred to siliconized Eppendorf tubes containing 0.5 ml of phenol prewarmed to 65°C, vortexed for 30 s at high speed, and incubated at 65°C for 30 min with 30-s vortexing at 10-min intervals. The mixture was placed on ice for 2 min and centrifuged for 5 min to separate the phases. The aqueous phase was removed to a new tube and extracted once with phenol-chloroform-isoamyl alcohol (25: 24:1) and once with chloroform. Sodium acetate (pH 5.2) was added to 0.3 M, and the RNA was precipitated by the addition of 2 volumes of 95% ethanol. Pellets were rinsed in 70% ethanol, dried, and resuspended in water at a nucleic acid concentration of 1 mg/ml.
Primer extensions were performed as described previously (4) in 20-,ul reactions with 10 ,ug of total RNA and 0.2 ng of each end-labeled oligonucleotide primer. Primer extension reactions with primers YSTR and SCR1 were performed simultaneously (Fig. 4B) In vivo structure probing. In vivo structure probing was performed as described previously (4), using a set of isogenic strains carrying different U2 alleles. H170 has the genotype MATot ura3-52 leu2-3,112 his4-619 lys2 snr2O::URA3 and carries a LYS2 centromere plasmid with a marked U2 gene to cover the U2 disruption (4). The indicated U2 alleles were introduced on a LEU2 centromere plasmid, and loss of the marked wild-type U2 gene was selected by plasmid shuffling on a-aminoadipate medium (12) . The sites of modification in U2 RNA were mapped by primer extension (26, 41) In vivo splicing extracts and assays. Strain IH1097 (A TTa pep4-3 prbl prcl ura3-52 leu2-3,112 trpl) was transformed with YEp24-PRP9-3'HA (a gift of M. Rosbach), which carries the epitope-tagged PRP9 gene (1) , and whole cell extract was prepared as described by Lin et al. (34) and was assayed as described by McPheeters et al. (37) . Actin pre-mRNA substrate, T7 U2 RNA, and T7 rRNA were synthesized in vitro by using T7 RNA polymerase essentially as described by Milligan and Uhlenbeck (39) . The template for substrate synthesis is a wild-type actin intron and is described by Zavanelli and Ares (56) . The template for T7 U2 RNA was generated by amplifying the wild-type U2 sequence from a plasmid by using the following oligonucleotides: T7 U2 (5'-CAAGCTTAATAC GACTCACTATAGGACGAATCTCThI7GCC-3') and U2-3' (AAAAGAGCGAACGGGAAG-3').
A smaller transcript was consistently observed in addition to the full-length U2. This smaller transcript functioned as efficiently as the wild type in the reconstitution experiment, consistent with previous results (37 (53) . Monoclonal antibody 12CA5 was purchased from Berkeley Antibody Co. anti-Prpllp serum was a generous gift of T.-H. Chang (10) . Anti-Prp2lp serum was a generous gift of J. Arenas (2) .
Protein A-Sepharose CL-4B (PAS; Sigma) was suspended in NET (50 mM Tris-Cl [pH 7.4], 0.05% Nonidet P-40, 150 mM NaCl) at 100 mg/4 ml, incubated at 4°C with slow rotation for 1 h, and washed three times with 4 ml of NET. A fraction of the prewashed PAS equivalent to a 10-to 20-,u packed volume was suspended in 0.4 ml of NET, and antibodies were bound for 4 to 8 h by rotation at 4°C. PAS-bound antibodies were washed three times with 0.4 ml of NET prior to incubation with extract. PAS-antibody complexes were suspended in 0.4 ml of NET and incubated in siliconized 0.5-ml tubes with rotation for 1 h at 4°C with a maximum of 20 (24, 40) , thereby bringing the endogenous wild-type U2 gene under GAL control (Fig. 1B) . We introduced plasmids carrying a mutant U2 allele under constitutive control of the natural U2 promoter into these strains. Under these circumstances, cells grown on glucose effectively express only the mutant U2. If the prp mutation is synthetic lethal with the U2 allele, the cells will fail to grow on glucose at a temperature permissive for both single mutants alone (26°C) (Fig. 1B) . We refer to this as conditional synthetic lethality, and in our case it can be induced by shifting cells from galactose to glucose.
We chose a set of well-studied PRP genes (2, 13, 21, 45, 54) , all known to encode products required for early steps in spliceosome assembly (prp3, pip4, prpS, prp8, prp9, prpll, pip19, and prp2l). An (4) . We constructed over 250 double-mutant combinations, each carrying a single prp temperature-sensitive mutation and a plasmid-borne mutant U2 allele complemented in a galactosedependent fashion by the GAL-controlled wild-type U2 gene. We tested the strains for growth on glucose at temperatures permissive for either single mutant alone (26°C). A sample of these data is shown in Fig. 1C , and the rest of the data are summarized in tabular form next to the secondary structure of this region of yeast U2 (Fig. 2) .
In no case did we observe synthetic lethality with prp3, prp4, prp8, or prpl9 and any U2 mutation, demonstrating that the synthetic lethal phenotype cannot be generated simply by combining any two mutations in the splicing apparatus or by combining any prp mutation with a U2 mutation (see also (3, 25) , and dlBD+III is the same as dlBD except that nucleotides 633 to 650 have been included to restore a stem-loop that is structurally equivalent to metazoan stem-loop III (4). reference 46). In contrast, a subset of U2 alleles, most of which have no phenotype on their own, fail to grow in combination with mutations in prpS, prp9, prpll, and prp2l (Fig. 2) . At this level of analysis, we conclude that a discrete subset of Prp proteins (Prp5p, Prp9p, Prpllp, and Prp2lp) function closely with U2 snRNA during splicing. For the others (Prp3p, Prp4p, Prp8p, and Prpl9p), we can make no conclusion; either they are also in close functional association with U2 and we have not paired appropriate alleles of these genes to reveal an interaction, or these gene products do not function closely with U2.
The majority of U2 alleles that we tested display one of two patterns of lethality with theprp mutations: either they show no lethality at all, or they are lethal in combination with all members of the group prp9, prpll, and prp2l (Fig. 2) . Many U2 alleles are also synthetic lethal with prpS, in addition to prp9, -11, -21. The extreme overlap in pattern suggests that these splicing proteins make many of the same demands on U2 RNA structure for their function. A formal genetic interpretation of this result is that these gene products interact with U2 as a unit (for example as a protein complex) or interact separately (presumably sequentially) in very similar ways. Interaction as a unit is supported by evidence that PRP5, PRP9, PRPJ1, and PRP21 show synthetic lethal interactions with one another (46) , and a suppressor of prp9-1 called SPP91 (11) is an allele of PRP21 (2) . Results from the two-hybrid system have also detected protein-protein interactions between Prp2lp and both Prp9p and Prpllp (30, 31 Fig. 1C and 2) . Growth of the U56C prp5-l double mutant is only slightly growth impaired (data not shown), whereas the U56C prp5-3 double mutant grows very slowly.
Both the U56G prpS-J and U56G prp5-l and U56G prpS-3 double mutants are inviable. Two loop Ila mutations that are consistent with observed phylogenetic variation, C59U (found in mammals and plants [3, 22] ) and A57G (found only in Tetrahymena thermophila [43] ), show no synthetic lethal defect. The other single mutation in the loop, A57C, is lethal with prp9, -11, and -21 and shows some degree of growth inhibition with prp5. The triple mutation in the loop (tmB) is also synthetic lethal. No synthetic lethality has been observed with mutations in the conserved complementarity to the loop Ila (residues 98 to 105; mutant G100A or tmB'; Fig. 2) .
The structure of stem loop Ilb is also necessary for function with mutant prp gene products. This element is phylogenetically conserved but dispensable in a wild-type PRP background, in which its deletion produces no apparent growth defect (4) . Mutations in stem Ilb (tmC and tmC'), as well as complete deletion of the stem, nucleotides 69 to 85 (AC), are synthetic lethal with the group prp5, -9, -11, and -21 (Fig. 2) . The compensatory combination of tmC and tmC' (smC) is not synthetic lethal with these prp mutations, demonstrating that it is the structure of stem Ilb, rather than the primary sequence, that is important for cooperative function with the prp gene products. We also tested a set of other mutations, including the large internal deletion (nucleotides 123 to 1081) spanning the yeast equivalent of stem III (dlBD [3, 25] ) and a derivative of this mini-U2 into which just the stem III-homologous sequence (nucleotides 633 to 650) has been placed (dlBD+III [4] ). Neither of these is synthetic lethal with prp5, but both are synthetic lethal with prp9 and -21, and growth is severely inhibited in prpll . A single base change downstream from the Sm site (C121U) shows no synthetic lethality (Fig. 2) . Five mutations in U2 stem I in a region that interacts with U6 (U23G, U23C, C22G, C22A, and A27C U28C [35] ) were also tested with the prp5-3 mutant. Strains with all of these mutations are aphenotypic in a wild-type background except for the A27C U28C mutant, which grows slowly at 25°C (35) . No additional growth inhibition or lethal phenotype was observed for any of these combinations (data not shown), supporting the interpretation that the synthetic lethal interactions are restricted to distinct functional domains of U2 RNA.
Two independently isolated alleles of prp5 and two of prp9 are available, and we have tested them to see if they differ in their requirements for U2 function. The two alleles ofprp9 give identical patterns of synthetic lethality (not shown), consistent with the conclusion (31) that these two mutations are in the same functional domain of the Prp9p protein. The pp5-1 allele shows fewer synthetic lethal interactions than the prpS-3 allele, with no additional interactions not shown by the prp5-3 allele. This is consistent with a quantitative effect, especially considering that the temperature-sensitive growth phenotype of prp5-l is leakier than that of prpS-3. Until more about functional domains of the Prp5 protein is known, we cannot exclude the possibility that these effects are due to qualitative differences in the functions of the mutant proteins. We conclude that four splicing proteins, those encoded by the PRP5, -9, -11, and -21 genes, are individually in close functional association with U2 RNA (see also reference 46) and that this cooperative function is exquisitely sensitive to alterations in the structured region of U2 encompassing stem loops Ila and Ilb.
Splicing is inhibited in cells carrying lethal double mutations. Genetic results alone are inadequate to understand the nature of functional relationships between gene products at the cell and molecular levels. To demonstrate that the synthetic lethal phenotype is associated with an increased splicing defect in vivo, we measured ratios of spliced to unspliced U3 in our GAL-dependent synthetic lethal strains after a shift to glucose at permissive temperatures (Fig. 3A) . Many of the U2 mutations that we tested confer no splicing defect at 30°C (4), and many prp mutations have only subtle splicing defects at 23°C. In all cases of synthetic lethality, unspliced pre-U3 accumulates more readily in the double mutant than in either a single prp mutant with wild-type U2 or a strain carrying mutant U2 and wild-type PRP alleles. Note that although the prp4 strains accumulate substantial levels of pre-U3 in combination with wild-type U2, these levels do not increase with mutant U2, and prp4 is not synthetic lethal. Synthetic lethal combinations with prp5, -9, -11, or -21 accumulate unspliced U3 after the shift to glucose. Even the nonlethal but mildly growth impaired combination of U2 U56C with prp5-l shows splicing inhibition comparable to the lethal combinations (Fig.  3A, lane 11) . We conclude that the double-mutant combinations that lead to synthetic lethality also specifically result in the inhibition of splicing in vivo.
Mutant U2 snRNA does not accumulate in cells carrying a prpS, -9, -11, or -21 mutation. (Fig. 3B) . In all cases, the failure of mutant U2 snRNA to accumulate correlates precisely with synthetic lethality, suggesting that cells may die as a result of the absence of U2 snRNPs. In the case of the double mutant U56C prpS-1 U2 RNA, stability is not lost (Fig. 3B, (Fig. 2) , we would expect loop mutations that disrupt the stem to cause synthetic lethality as well. To refine our understanding of the effect of some of the U2 mutations on U2 structure as an aid in interpreting the synthetic lethal alleles, we performed structure probing on mutant U2 snRNAs in vivo (Fig. 4) , using chemical modification by dimethyl sulfate (4). U56G and tmB cause an increase in the reactivity of adjacent stem nucleotides (Fig. 4) , introducing the possibility that failure of these mutants to function with altered prp gene products may be indirectly mediated by their impact on stem Ila structure. In the case of U56C and A57C, however, structure probing reveals no such perturbation, suggesting that these residues contribute to a functional interaction through their impact on primary sequence products that we identified by genetic interactions might be physically associated with one another in a splicing complex. Each of the proteins Prp5p, -9p, -llp, and -21p is individually required for the formation of the prespliceosome (Prp5p [46] , Prp9p [1] , Prpllp [10, 51] , and Prp2lp [2] ). Little is known about participation of the yeast U2 snRNP in complexes prior to its association with the prespliceosome. We obtained antiPrpllp (10) and anti-Prp2lp antibodies (2) and a PRP9 gene tagged with an epitope (hemagglutinin) recognized by a commercially available monoclonal antibody (12CA5) (1) . We introduced the tagged PRP9 gene on a high-copy-number plasmid into a wild-type yeast strain, prepared splicing extracts, and used the antibodies to assay the formation of splicing complexes containing labeled splicing substrate and the different proteins under identical conditions (Fig. 5) . Since the strain carries a wild-type PRP9 gene in the chromosome, not all of the Prp9p in the extract can be recognized by the antitag antibody. Nonetheless, in agreement with reports on Prp9p (1), Prpl ip (10, 46) , and Prp2lp (2), we observe splicing complexes containing unreacted pre-mRNA and very little if any intermediate or product RNAs, suggesting that the proteins either leave the spliceosome before the first step of splicing or remain in the spliceosome but are obscured from the antibody probe before the first step of splicing (1, 2, 46) .
The antibodies that we used have been previously characterized and shown to precipitate endogenous U2 snRNPs from extracts (1, 2, 46 scribed, we assessed pre-mRNA-Prp complex formation in extracts depleted of U2 snRNP. When U2 is destroyed by oligonucleotide-directed RNase H digestion (32, 37), complexes containing pre-mRNA and any of the proteins are not detected (Fig. 5) . This finding is in agreement with results for Prp9p (1) and demonstrates that association of Prpllp or Prp2lp with pre-mRNA requires intact U2 snRNP. We conclude that formation of immunoprecipitable complexes containing Prp9p, -llp, or -21p and pre-mRNA requires intact U2 snRNA. Additional data for mutant pre-mRNA substrates indicates that the formation of the complexes that we observe is dependent on a correct branchpoint signal in pre-mRNA (not shown), in agreement with work of others (2, 46) . Taken together, the data indicate that in the presence of ATP, all three proteins bind the pre-mRNA either in conjunction with or as part of the U2 snRNP. We have not assayed complex 1 2 3 4 5 6 7 8 9 FIG. 6. Pre-mRNA complexes containing Prp9p and Prp2lp also contain Prpllp. Splicing reaction mixtures were cleared of immunoprecipitable complexes by using nonimmune (non-imm.) serum (lanes 2 to 5) or an anti-Prpllp antibody (a-PRPl1; lanes 6 to 9). Pre-mRNA complexes containing Prpllp were removed from the extract, and a second precipitation was performed with nonimmune serum (lanes 2 and 6), 12CA5 (lanes 3 and 7) , or an anti-Prpllp (a-PRP11; lanes 4 and 8) or anti-Prp2lp (a-PRP21; lanes 5 and 9) antibody. Symbols at the left represent splicing substrate, intermediates, and products. formation in ATP-depleted extracts; it is possible that one or more of the proteins interact with the pre-mRNA in the absence of ATP as reported previously (46) .
Immunoprecipitable pre-mRNA complexes that contain Prp9 or Prp2lp also contain Prpllp. The data presented above indicate that splicing complexes containing each of the three proteins are similar in that they contain unreacted pre-mRNA and require U2 snRNP for their formation. The data do not show whether they are in the same complex together. In addition, the genetic results (Fig. 2) do not distinguish between models involving sequential or simultaneous interaction of the proteins with U2. Although genetic data (11, 46) and results from the two-hybrid system (30, 31) suggest that proteins of this group interact, we wanted to determine if the three proteins are in the same complex at the same time with pre-mRNA. We performed a double-immunoprecipitation experiment (Fig. 6 ) in which radioactive premRNA was added to a splicing reaction. After incubation to allow splicing complex formation, the splicing reaction was chilled and diluted, and anti-Prpllp antibody was added in excess to remove all formed splicing complexes containing Prpllp. The supernatant from which all immunoprecipitable Prpllp-containing splicing complexes had been removed was then challenged with a second antibody against Prp9p(tag) 14, 1994 C== t mixture with a nonimmune serum did not prevent the subsequent precipitation of Prp9p, Prpllp, or Prp2lp-containing complexes (Fig. 6, lanes 3 to 5) , removal of all Prpl lpcontaining complexes removed all complexes containing Prp9p(tag) and Prp2lp (lanes 7 and 9). This finding indicates that immunoprecipitable Prp9p and Prp2lp splicing complexes all contain Prpllp. We conclude that Prp9p and Prp2lp interact only with pre-mRNA in a class of Prpllp-containing splicing complexes whose formation is dependent on U2 snRNP.
Formation of complexes containing synthetic U2 RNA and Prp9p, Prpllp, and Prp2lp. Having demonstrated genetic interactions between U2 RNA and Prp5p, Prp9p, Prpllp, and Prp2lp, contribution of these proteins to U2 RNA stability in vivo, and participation of several of these components in a complex with pre-mRNA in vitro, we wanted to detect more direct physical interactions, if any, between U2 RNA and these proteins. Antibodies against Prp9p have been shown to precipitate endogenous U2 snRNPs from splicing reactions in the absence of added pre-mRNA with specificity at 100 mM NaCl but poorly at 200 mM (1) . From a similar experiment using anti-Prpl lp antibodies, Ruby et al. (46) concluded that one or more snRNPs in addition to U2 could be recognized at 150 mM NaCl but not at 200 mM. In an analogous experiment on Prp2lp (2), only 50 and 200 mM NaCl were tested; specificity of snRNP precipitation was not achieved at 50 mM (by comparison with preimmune serum), and at 200 mM no precipitation was observed. Given the presence of all three proteins in a common complex (Fig. 6 ) and the salt-sensitive nature of the association of Prp9p with U2 (1), we attempted to reconstitute U2-protein complexes by using synthetic U2 RNA, with the expectation that salt concentrations lower than 200 mM might be necessary for their detection. Addition of synthetic U2 RNA to yeast splicing extracts depleted of endogenous U2 RNA can reconstitute splicing (37) , arguing that any important functional interactions between Prp proteins and synthetic U2 must occur in such a reconstituted system.
We mixed yeast splicing extracts depleted of endogenous U2 RNA with different synthetic RNAs and immunoprecipitated them with antibodies against Prp9p(tag), Prpllp, and Prp2lp (Fig. 7) . Synthetic U2 snRNA was coprecipitated by antiPrpllp (Fig. 7, lane 6) , whereas a transcript of similar length from Escherichia coli 23S rRNA was not (lane 5). Precipitation of synthetic U2 RNA by anti-Prpllp can be competed for by excess unlabeled synthetic U2 RNA (lane 7) but not by an excess of the rRNA transcript (lane 8). Anti-Prp2lp and anti-Prp9p(tag) also specifically precipitate synthetic U2 RNA in the presence of excess nonspecific competitor (lanes 9 and 10), whereas control nonimmune serum did not (lane 4). We conclude that the Prp9p, -lip, and -21p specifically bind synthetic U2 RNA after incubation in splicing extracts depleted of endogenous U2 and that this association does not require the addition of pre-mRNA. The binding of these proteins to the RNA may be mediated through other proteins or snRNPs present in the extract. These antibodies have been shown to precipitate other snRNAs along with U2 snRNA from untreated splicing extracts (2, 46 several well-characterized splicing proteins might function closely with U2 snRNA in splicing (Fig. 1) . We constructed strains representing all combinations of 27 different U2 alleles with 10 different prp mutations and found three main patterns of synthetic lethality. U2 mutations were synthetic lethal with either (i) none of the tested prp mutations, (ii) the set containingprp9, -11, and -21, or (iii) the set containingprp5, -9, -11, and -21 (Fig. 2) . This finding indicates that these proteins interact functionally with U2 snRNA (see also reference 46) through discrete U2 RNA structures. In vivo, synthetic lethality is accompanied by failure of mutant U2 to accumulate, indicating that the mutant Prp proteins are unable to carry out a function required for U2 snRNP assembly with the mutant U2 RNA (Fig. 3B) . Some of the U2 RNAs that display synthetic lethality are not detectably misfolded, indicating that subtle contributions to structure can have important consequences for cooperative function with Prp proteins (Fig. 4) . Using yeast splicing extracts containing wild-type components, we show that three of the proteins are in the same complex with pre-mRNA (Fig. 6 ) and that formation of this complex requires intact U2 snRNP (Fig. 5) . These three proteins can also be incorporated into complexes containing synthetic U2 RNA in the absence of added pre-mRNA (Fig. 7) .
U2 snRNA function is overspecified. The observation that silent U2 mutations become lethal when PRP function is compromised exposes the functional importance of phylogenetically conserved but clinically dispensable structures of yeast U2 snRNA (4) . The apparent dispensability of highly conserved U2 RNA structures in yeast was initially surprising; however, viewing U2 RNA structure through the lens of a prp mutation reveals that the conserved structural elements of U2 are critical (Fig. 2) and contribute to the stability and function of the RNA (Fig. 3B) Deletion of the large internal region of U2 that contains a structure homologous to mammalian stem III is also synthetic lethal. We noted that the accumulation of the internal deletion (dlBD) U2 was reduced (25) and reported that addition of stem III sequences (dlBD+I1I) did not rescue the poor accumulation (4) . The synthetic lethality in the case of these constructs could either be direct, if the internal sequences were required to make contacts with the protein(s), indirect through effects on folding of adjacent RNA required for the direct interactions, or indirect through additional reduction of the already low levels of stable U2 snRNP by other independent mechanisms. Since the stability of the dlBD and dlBD+IIl U2 RNAs is known to be compromised (4, 25) and there is loss of stable U2 RNA in other synthetic lethal combinations (Fig.  3B) , we favor the hypothesis of an indirect mechanism that further reduces U2 snRNP stability. Surprisingly, one U2 mutation, C121U just downstream of the Sm site, does slightly affect U2 RNA accumulation in a wild-type PRP background (4); the loss of stability in this case is insufficient to cause synthetic lethality with mutant Prp9p, -llp, or -21p (Fig. 2) . The sequence of this region influences the function of humanyeast U2 chimeras in yeast cells (52) , possibly through an effect on stability. Since a synthetic stability defect (Fig. 3B) (30) . Synthetic lethal interactions have also been reported to occur between every pairwise combination of the group prp5, -9, -11, and -21 (46) . Overexpression suppression (46, 55a) and overexpression lethality (55a) have also been observed with specific pairwise combinations.
In spite of all of the genetic data, direct biochemistry to demonstrate a stable complex between these proteins is limited. An elaborate regimen for complementing prpll-inactivated extracts with in vitro-synthesized Prpllp hinted that Prpllp might be part of a complex (10) . Heat-inactivated extracts from temperature-sensitive prp9 and prpll strains do not complement each other well for splicing in vitro, although each can be complemented by a heat-inactivated prp5 extract (46) , suggesting that Prp9p and Prpllp may be part of the same functional unit in vitro, but that Prp5p activity is more diffusible. The ability of anti-Prpllp antibodies to remove all Prp9p and Prp2lp protein associated with pre-mRNA (Fig. 6) indicates that neither Prp9p nor Prp2lp can form stable splicing complexes without Prpllp. Recently a weak Prpllp interaction with pre-mRNA in an ATP-depleted extract has been reported (46) . Since stable U2 snRNP addition is an ATP-dependent step (32, 33, 50) , it was suggested that Prpllp associates with the commitment complex prior to U2 snRNP addition (46) . We have also observed ATP-independent coimmunoprecipitation of pre-mRNA with anti-Prpllp as well as anti-Prp9p(tag) and anti-Prp2lp. In addition, U2 snRNP has been reported to associate with pre-mRNA in extracts depleted of ATP in both the mammalian (28) and mutant yeast (33) extracts. Unfortunately, unless ATP-independent complexes can be chased into the functional splicing pathway, their relevance to splicing is uncertain. In any event, our U2 depletion experiments do not exclude the possibility that U2 snRNP is required in the presence of ATP to stabilize a preexisting ATP-independent interaction between Prpllp and pre-mRNA.
Our data provide a rationale for the requirement of several elements in the stable addition of U2 snRNP to pre-mRNA during spliceosome assembly. Stem loop Ila is required for this step (56) and for cooperative function with Prp5p, -9p, -llp, and -21p (Fig. 2) , each of which is independently required for the same step (1, 2, 31, 46) . The association of Prp9p and Prpllp with endogenous U2 snRNA has been demonstrated (1, 46) ; however, reconstitution of these interactions in the absence of added pre-mRNA suggests that these proteins as well as Prp21p associate with U2 snRNA prior to the association of U2 snRNP with the pre-mRNA. Since intact U2 snRNA is required for association of all three proteins with pre-mRNA in the presence of ATP (1) (Fig. 5) , and conversely each of the proteins is required for the association of U2 snRNP with the pre-mRNA (1, 2, 31, 46) , the simplest explanation for the genetic and biochemical interdependence is that all of the components are part of the same functional unit, the U2 snRNP. The contribution of the interactions to U2 RNA stability (Fig. 3B) provides critical evidence that these associations contribute to the integrity of U2 snRNP in vivo. In the case of Prp5p, a nucleotide binding motif and similarity to helicases argues for additional functions with the U2 snRNP (16) but does not exclude a structural role as well.
snRNP proteins or splicing factors? In mammalian systems, the U2 snRNP as isolated from the cell exists in two forms that differ (at least) in their association with a complex of proteins (6; see also reference 55) that include a proposed Prp9p homolog (8) and a Prpllp homolog (7) . The association of these mammalian proteins with U2 is salt labile and reversible (6, 8, 9) and requires the 5' half of U2 RNA for binding to the snRNP (6) . In addition, the proteins are required for stable U2 snRNP binding to the assembling spliceosome, a property expected of U2 snRNP proteins (5, 8, 9) . Given this, the question arises as to whether Prp9p, PrplIp, and Prp2lp and even Prp5p should be considered snRNPs or splicing factors, or whether it is useful to make such distinctions. By the definition of salt-stable association with the core snRNP particles (in mammals [6, 9] ; in S. cerevisiae for at least Prp9p [1] ), they are clearly extrinsic factors. On the other hand, they associate specifically with U2 snRNP in the absence of added pre-mRNA (1, 6, 9) and contribute to snRNP stability in vivo (Fig. 3B) , as does, for example, a yeast Sm protein (47) . Because in yeast cells they become undetectable in premRNA-containing complexes after a point prior to the first substrate cleavage-ligation reaction, it has been suggested that they become buried, or their association with the spliceosome is transient (1, 2, 46) (Fig. 5) . Transient association is reminiscent of other splicing factors such as Prp2p (29) , Prpl6p (48) , and Prp22p (15) , as well as the Ul and U4 snRNPs (20, 21) . In the end, the distinction between intrinsic snRNP proteins and extrinsic splicing factors may become blurred. Genetic interactions such as synthetic lethality and the molecular phenotypes underlying them provide an additional context in which the function of factors that cooperate with snRNAs during splicing may be understood.
